Outlook Therapeutics (OTLK) Tax Provisions: 2015-2024
Historic Tax Provisions for Outlook Therapeutics (OTLK) over the last 10 years, with Sep 2024 value amounting to $2,800.
- Outlook Therapeutics' Tax Provisions rose 99.97% to -$805 in Q3 2020 from the same period last year, while for Sep 2020 it was -$6.7 million, marking a year-over-year increase of 5.33%. This contributed to the annual value of $2,800 for FY2024, which is negligibly% changed negligibly from last year.
- Per Outlook Therapeutics' latest filing, its Tax Provisions stood at $2,800 for FY2024, which was down 0.00% from $2,800 recorded in FY2023.
- In the past 5 years, Outlook Therapeutics' Tax Provisions registered a high of $2,800 during FY2022, and its lowest value of -$3.3 million during FY2020.
- Moreover, its 3-year median value for Tax Provisions was $2,800 (2024), whereas its average is $2,800.
- Data for Outlook Therapeutics' Tax Provisions shows a peak YoY soared of 100.06% (in 2021) over the last 5 years.
- Over the past 5 years, Outlook Therapeutics' Tax Provisions (Yearly) stood at -$3.3 million in 2020, then soared by 100.06% to $2,000 in 2021, then surged by 40.00% to $2,800 in 2022, then remained steady at $2,800 in 2023, then remained steady at $2,800 in 2024.